pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 29·1 min read
save

California hospital lawsuits reveal forced McKinsey ties and surprise ER chain profits

Jun 29, 2026·read at STAT ↗RegulatoryNegative

Unredacted comments from recent California hospital lawsuits show that hospital executives admitted to a "forced" partnership with consulting firm McKinsey, raising questions about the influence of outside advisors on hospital operations.

The lawsuits also touch on broader issues such as who controls the Medicaid market and the use of GLP-1 drugs, highlighting ongoing concerns about cost and access in the health system.

In a separate note, the newsletter points to Nutex Health, an emerging emergency‑room chain that largely avoids Medicare patients and relies on federal arbitration to secure higher payments, a model that critics say exploits billing disputes for profit.

These disclosures illustrate the financial and regulatory pressures facing hospitals and health‑care providers, and suggest increased scrutiny of consulting relationships and unconventional revenue strategies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Unredacted comments from California hospital lawsuits show stunning admissions and a ‘forced’ McKinsey collaboration”

read at STAT ↗
514 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor3

related stories

  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 18STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreSTAT
  • May 15FDA hold puts Aardvark Prader-Willi drug in limboBioPharma Dive
  • May 15India’s pharma industry is going global. But can it catch up to China?BioPharma Dive
  • May 14Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Preventiononclive